Skip to main
DYN

Dyne Therapeutics (DYN) Market Capitalization Overview

Market Cap: $2.96B as of Jan 8, 2026

$2.96B
$58.07M (2.00%)past month
As of Jan 8, 2026, Dyne Therapeutics (DYN) has a market capitalization of $2.96B. Over the past 30 days, its market cap has increased by 1.69%, while in the last 12 months, it has decreased by -6.65%.

Market capitalization represents the total value of Dyne Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Dyne Therapeutics (DYN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Dyne Therapeutics (DYN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Dyne Therapeutics (DYN) Market Cap History

DateMarket CapChange
Dec 1, 2025$2.95B-14.18%
Nov 3, 2025$3.43B+92.88%
Oct 1, 2025$1.78B-7.41%
Sep 2, 2025$1.93B+34.33%
Aug 1, 2025$1.43B+44.91%
Jul 1, 2025$986.63M-31.65%
Jun 2, 2025$1.45B+5.95%
May 1, 2025$1.37B+30.49%
Apr 1, 2025$1.05B-16.72%
Mar 3, 2025$1.26B-11.18%
Feb 3, 2025$1.42B-45.52%
Jan 2, 2025$2.60B-13.05%

Dyne Therapeutics (DYN) End of Year Market Cap History

DateMarket CapChange
2026$2.96B-6.65%
2025$3.17B+32.00%
2024$2.40B+193.72%
2023$816.30M+35.11%
2022$604.16M-1.39%
2021$612.68M

FAQs About Dyne Therapeutics (DYN) Market Cap

As of Jan 8, 2026, the market capitalization of Dyne Therapeutics (DYN) is $2.96B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Dyne Therapeutics’s market capitalization has increased by 2.00%, changing from $2.90B to $2.96B as of Jan 8, 2026.

In the last 3 months, Dyne Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Dyne Therapeutics’s market capitalization increased from $2.40B in January to $3.17B in December, reflecting a 32% change.

In the past five years, Dyne Therapeutics (DYN) has had a compound annual growth rate (CAGR) of 38.88% in market capitalization. This means its market cap has grown at an average rate of 38.88% per year.

Dyne Therapeutics (DYN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.